Cargando…
Evaluating outcomes associated with a discharge action plan employing single-dose home use of ondansetron in patients with acute gastroenteritis
Acute gastroenteritis accounts for 1–2 million annual pediatric emergency department visits in the US. The current literature supports the use of antiemetics, such as ondansetron, in the emergency department, reporting improved oral rehydration, cessation of vomiting, and reduction in the need for i...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753972/ https://www.ncbi.nlm.nih.gov/pubmed/27147857 http://dx.doi.org/10.2147/OAEM.S27462 |
_version_ | 1782415951756525568 |
---|---|
author | Haines, Elizabeth van Amerongen, Robert Birkhahn, Robert Wen, Wendy Gaeta, Theodore |
author_facet | Haines, Elizabeth van Amerongen, Robert Birkhahn, Robert Wen, Wendy Gaeta, Theodore |
author_sort | Haines, Elizabeth |
collection | PubMed |
description | Acute gastroenteritis accounts for 1–2 million annual pediatric emergency department visits in the US. The current literature supports the use of antiemetics, such as ondansetron, in the emergency department, reporting improved oral rehydration, cessation of vomiting, and reduction in the need for intravenous rehydration. However, there remains concern that using these agents may “mask alternative diagnoses” and negatively impact patient care. We present a case series of 29 patients who received a pediatric emergency department discharge action plan which allowed for a dose of ondansetron to be dispensed by the clinician at the time of discharge. Patients were instructed to administer the ondansetron at home for treatment of ongoing nausea and vomiting any time after 6 hours from the time of emergency department discharge. These patients were followed up at 3–5 days following discharge to assess for outcomes. Implications of this discharge action plan and future directions are discussed. |
format | Online Article Text |
id | pubmed-4753972 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-47539722016-05-04 Evaluating outcomes associated with a discharge action plan employing single-dose home use of ondansetron in patients with acute gastroenteritis Haines, Elizabeth van Amerongen, Robert Birkhahn, Robert Wen, Wendy Gaeta, Theodore Open Access Emerg Med Case Series Acute gastroenteritis accounts for 1–2 million annual pediatric emergency department visits in the US. The current literature supports the use of antiemetics, such as ondansetron, in the emergency department, reporting improved oral rehydration, cessation of vomiting, and reduction in the need for intravenous rehydration. However, there remains concern that using these agents may “mask alternative diagnoses” and negatively impact patient care. We present a case series of 29 patients who received a pediatric emergency department discharge action plan which allowed for a dose of ondansetron to be dispensed by the clinician at the time of discharge. Patients were instructed to administer the ondansetron at home for treatment of ongoing nausea and vomiting any time after 6 hours from the time of emergency department discharge. These patients were followed up at 3–5 days following discharge to assess for outcomes. Implications of this discharge action plan and future directions are discussed. Dove Medical Press 2012-03-26 /pmc/articles/PMC4753972/ /pubmed/27147857 http://dx.doi.org/10.2147/OAEM.S27462 Text en © 2012 Haines et al, publisher and licensee Dove Medical Press Ltd This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Case Series Haines, Elizabeth van Amerongen, Robert Birkhahn, Robert Wen, Wendy Gaeta, Theodore Evaluating outcomes associated with a discharge action plan employing single-dose home use of ondansetron in patients with acute gastroenteritis |
title | Evaluating outcomes associated with a discharge action plan employing single-dose home use of ondansetron in patients with acute gastroenteritis |
title_full | Evaluating outcomes associated with a discharge action plan employing single-dose home use of ondansetron in patients with acute gastroenteritis |
title_fullStr | Evaluating outcomes associated with a discharge action plan employing single-dose home use of ondansetron in patients with acute gastroenteritis |
title_full_unstemmed | Evaluating outcomes associated with a discharge action plan employing single-dose home use of ondansetron in patients with acute gastroenteritis |
title_short | Evaluating outcomes associated with a discharge action plan employing single-dose home use of ondansetron in patients with acute gastroenteritis |
title_sort | evaluating outcomes associated with a discharge action plan employing single-dose home use of ondansetron in patients with acute gastroenteritis |
topic | Case Series |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4753972/ https://www.ncbi.nlm.nih.gov/pubmed/27147857 http://dx.doi.org/10.2147/OAEM.S27462 |
work_keys_str_mv | AT haineselizabeth evaluatingoutcomesassociatedwithadischargeactionplanemployingsingledosehomeuseofondansetroninpatientswithacutegastroenteritis AT vanamerongenrobert evaluatingoutcomesassociatedwithadischargeactionplanemployingsingledosehomeuseofondansetroninpatientswithacutegastroenteritis AT birkhahnrobert evaluatingoutcomesassociatedwithadischargeactionplanemployingsingledosehomeuseofondansetroninpatientswithacutegastroenteritis AT wenwendy evaluatingoutcomesassociatedwithadischargeactionplanemployingsingledosehomeuseofondansetroninpatientswithacutegastroenteritis AT gaetatheodore evaluatingoutcomesassociatedwithadischargeactionplanemployingsingledosehomeuseofondansetroninpatientswithacutegastroenteritis |